← back to search

Olivier Meyer

Université Claude Bernard Lyon 1 · FR
Area of research
Rheumatology · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Rheumatoid arthritis, Internal medicine, Infliximab, Rheumatology, and Immunology.
h-index
citations
562
works
9
NIH funding
primary concept
email

Recent publications

Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance
Journal of Autoimmunity 2017cited by 84position: middledoi
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
Autoimmunity Reviews 2017cited by 37position: middledoi
Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
RMD Open 2015cited by 73position: middledoi
Body mass index and response to infliximab in rheumatoid arthritis.
PubMed 2015cited by 51position: middle
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry
Annals of the Rheumatic Diseases 2015cited by 50position: middledoi
Five-year Favorable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data from the ESPOIR Cohort
The Journal of Rheumatology 2013cited by 48position: middledoi
Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort
Annals of the Rheumatic Diseases 2013cited by 47position: middledoi
Body mass index influences the response to infliximab in ankylosing spondylitis
Arthritis Research & Therapy 2012cited by 102position: middledoi
Brief Report: Candidate gene study in systemic sclerosis identifies a rare and functional variant of the <i>TNFAIP3</i> locus as a risk factor for polyautoimmunity
Arthritis & Rheumatism 2012cited by 70position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2013–2015)Jean Sibilia · Immune Regulation (United Kingdom)3 papers (2013–2015)Philippe Dieudé · Université Claude Bernard Lyon 13 papers (2012–2015)Sébastien Ottaviani · Université Claude Bernard Lyon 12 papers (2012–2015)Anaïs Gardette · Université Claude Bernard Lyon 12 papers (2012–2015)Bernard Combe · Université Claude Bernard Lyon 12 papers (2013–2015) · 2 papers (2013–2013)Florence Tubach · THERANOSCAN : Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules2 papers (2012–2015) · 2 papers (2013–2015) · 2 papers (2013–2015)Maxime Dougados · Institut Pasteur2 papers (2015–2015) · 2 papers (2015–2015) · 2 papers (2013–2015)Maxime Dougados · Centre Hospitalier Universitaire de Bordeaux2 papers (2013–2013) · 2 papers (2015–2015)Élisabeth Palazzo · Université Claude Bernard Lyon 12 papers (2012–2015)Joëlle Bénessiano · Center for Assessment1 papers (2013–2013) · 1 papers (2012–2012) · 1 papers (2015–2015) · 1 papers (2015–2015)